The largest database of trusted experimental protocols

Pact2 ad vector

Manufactured by Takara Bio

The PACT2 AD vector is a recombinant adenoviral vector designed for gene delivery applications. It provides a platform for the expression of target genes in a variety of cell types. The core function of the PACT2 AD vector is to facilitate the efficient transduction and expression of genetic material in various experimental and research settings.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using pact2 ad vector

1

TRPM7 COOH-terminus Yeast-Two-Hybrid Screen

Check if the same lab product or an alternative is used in the 5 most similar protocols
The COOH-terminus of TRPM7 (residues 1120–1862) was subcloned into pBMT116 LexA vector to make the “bait” vector LexA-CTERM. A rat brain prey library in the pACT2 AD vector was purchased from Clontech Laboratories, Inc (Mountainview, CA). A yeast-two-hybrid screen was conducted following the manufacturer’s protocol for large-scale transformation. Positive interactions were identified by growth on selective media and a beta galactosidase assay before sequencing of purified plasmids. To conduct the directed Y2H beta galactosidase assay, the coiled-coil (CC) domain (residues 1120-1288) and kinase (KIN) domain (residues 1597–1862) of TRPM7 were subcloned into pBMT116 to make LexA-CC and LexA-KIN. The kinase-inactive LexA-CTERM (K1646R) mutant was made using QuikChange (Agilent Technologies, Santa Clara, CA) following the manufacturer’s protocol. The primers used to make the Y2H “bait” vectors are described in Supplementary Methods.
+ Open protocol
+ Expand
2

Yeast Two-Hybrid Assay for Drosophila Imp and Lin28

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full length CDS Drosophila Imp and Lin28 cloned in pACT2 AD vector (Clontech) to produce Gal4 transcriptional activation domain (TAD) and LexA DNA binding domain-(DBD) to generate TAD-Lin28 and TAD-Imp; and DBD-Lin28 and DBD-Imp respectively [42 (link)]). All constructs were verified by DNA sequencing. Various combinations of plasmids expressing TAD and DBD were transformed into the yeast strain YPH500 (MAT α, ade 2, his3, leu 2, lys2, trp1, ura3) harboring the pSH18-34 plasmid (lexAop- LacZ reporter) by the standard lithium acetate method. Independent transformants for each combination were patched onto glucose plates containing X-gal for 24–48 hours, followed by a beta-galactosidase liquid assay as described previously [43 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!